Advanced Tear Diagnostics (ATD), develops and markets a highly specialized point-of-care (POC) lab testing system designed specifically to assist Optometrists and Ophthalmologists in detecting and quantifying biomarkers associated with the diagnosis and treatment of a variety of external ocular disorders.
Headquartered in Birmingham, Alabama, ATD’s unique testing platform is the world’s first POC clinical lab system focused exclusively on eye care and is the first to receive FDA approval for the diagnostic testing of tears.
Marcus Smith – Chief Executive Officer
Senior executive with over 25 years experience in Strategic Planning, Operations, Mergers & Acquisitions and Business Development within the ophthalmic sector. Formerly served as President of Global Vision (Bogota, Colombia); Director – US Clinic Development, TLC The Laser Centers (Toronto, Ontario); Director of Acquisitions, Omega Health Systems (Memphis, TN) and President of MW Smith & Associates (Birmingham, AL).
Gene Wahnefried – Chief Finance & Operating Officer
Serial entrepreneur with over 25 years executive experience in Operations, Finance, Marketing, Sales, Business Development, Mergers & Acquisitions and Strategic Planning. Has taken multiple companies to successful exit events after achieving significantly higher revenues with substantial increases in profitability. Formerly served as CEO Integris Leadership, CEO Bay Mountain, President Matrix Corp, and Director Carrier Air Conditioning.
Jeffrey Busby – Chief Commercial Officer
Senior executive with over 25 years experience in the development and management of national and international ophthalmic medical device sales and support. Experience includes VP Sales and Marketing for Comprehensive Finance, US Director of Refractive Sales and Director of Global Strategic Accounts for Advanced Medical Optics (AMO), Division Manager for Alcon and Territory Manager for CooperVision Surgical Systems.